| Management of alloimmunized patients ST Nance ISBT Science Series 5 (n1), 274-278, 2010 | 389 | 2010 |
| Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay SJ Nance, P Arndt, G Garratty Transfusion 27 (6), 449-452, 1987 | 140 | 1987 |
| Polyethylene glycol: A new potentiator of red blood cell antigen–antibody reactions SJ Nance, G Garratty American journal of clinical pathology 87 (5), 633-635, 1987 | 110 | 1987 |
| Quantitation of fetal–maternal hemorrhage by flow cytometry: a simple and accurate method SJ Nance, JM Nelson, PA Arndt, HTC Lam, G Garratty American journal of clinical pathology 91 (3), 288-292, 1989 | 100 | 1989 |
| Correlation between in vivo hemolysis and the amount of red cell‐bound IgG measured by flow cytometry G Garratty, SJ Nance Transfusion 30 (7), 617-621, 1990 | 93 | 1990 |
| Donors with a rare pheno (geno) type HW Reesink, CP Engelfriet, H Schennach, C Gassner, S Wendel, ... Vox sanguinis 95 (3), 236-253, 2008 | 75 | 2008 |
| Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn SJ Nance, JM Nelson, J Horenstein, PA Arndt, LD Platt, G Garratty American journal of clinical pathology 92 (1), 89-92, 1989 | 55 | 1989 |
| Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab S Gupta, A Fenves, ST Nance, DB Sykes, WS Dzik Transfusion 55 (3), 623-628, 2015 | 50 | 2015 |
| International rare donor panels: a review S Nance, EA Scharberg, N Thornton, V Yahalom, I Sareneva, ... Vox Sanguinis 110 (3), 209-218, 2016 | 49 | 2016 |
| Fatal immune hemolytic anemia due to cefotetan G Garratty, S Nance, M Lloyd, R Domen Transfusion 32 (3), 269-271, 1992 | 49 | 1992 |
| How to find, recruit and maintain rare blood donors ST Nance Current opinion in hematology 16 (6), 503-508, 2009 | 44 | 2009 |
| Application of flow cytometry to immunohematology SJ Nance, G Garratty Journal of immunological methods 101 (1), 127-131, 1987 | 40 | 1987 |
| A review of the ISBT rare blood donor program G Woodfield, J Poole, ST Nance, G Daniels Immunohematology 20 (4), 244-8, 2004 | 36 | 2004 |
| PREDICTING HEMOLYTIC-DISEASE OF THE NEWBORN-A COMPARISON OF THE MONOCYTE MONOLAYER ASSAY AND THE CHEMILUMINESCENCE TEST GF Lucas, AG Hadley, SJ Nance, G Garratty Transfusion 32 (8), S19-S19, 1992 | 35 | 1992 |
| Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test GF Lucas, AG Hadley, SJ Nance, G Garratty Transfusion 33 (6), 484-487, 1993 | 33 | 1993 |
| Determination of zygosity using flow cytometric analysis of red cell antigen strength L Oien, S Nance, P Arndt, G Garratty Transfusion 28 (6), 541-544, 1988 | 30 | 1988 |
| Experience with RHD* weak D type 4.0 in the USA CM Westhoff, S Nance, C Lomas-Francis, M Keller, ST Chou Blood Transfusion 17 (2), 91, 2019 | 29 | 2019 |
| Variables affecting the enzyme-linked antiglobulin test when detecting and quantitating IgG red cell antibodies. N Postoway, SJ Nance, G Garratty Medical laboratory sciences 42 (1), 11-19, 1985 | 28 | 1985 |
| CORRELATION OF MONOCYTE MONOLAYER ASSAYS, MATERNAL ANTIBODY-TITERS, AND CLINICAL COURSE IN HEMOLYTIC-DISEASE OF THE NEWBORN (HDN) S Nance, J Nelson, P ONEILL, G Garratty Transfusion 24 (5), 415-415, 1984 | 24 | 1984 |
| COMPARISON OF A PRACTICAL DIFFERENTIAL AGGLUTINATION PROCEDURE TO FLOW-CYTOMETRY IN FOLLOWING THE SURVIVAL OF TRANSFUSED RED-CELLS N Postoway, S Nance, P ONeill, G Garratty Transfusion 25 (5), 453-453, 1985 | 23 | 1985 |
